Shigeru Yasue
Directeur/Membre du Conseil chez HuLA immune, Inc.
Profil
Shigeru Yasue is currently a Director at HuLA immune, Inc. He was previously a Director at TMS Co., Ltd.
Postes actifs de Shigeru Yasue
| Sociétés | Poste | Début |
|---|---|---|
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Directeur/Membre du Conseil | - |
Anciens postes connus de Shigeru Yasue
| Sociétés | Poste | Fin |
|---|---|---|
| TMS CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TMS CO., LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
